ExodusPoint Capital Management »

Syros Pharmaceuticals shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $673k 313k 2.15
2024-03-31 $829k 155k 5.35
2023-09-30 $427k 108k 3.95
2023-06-30 $373k 118k 3.15
2023-03-31 $325k 122k 2.67
2022-12-31 $123k 34k 3.60

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Johnson & Johnson Put Option (JNJ)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
NiSource (NI)
CMS Energy Corporation (CMS)
PPL Corporation (PPL)
Tesla Motors Put Option (TSLA)
Mondelez Intl Cl A (MDLZ)
Becton, Dickinson and (BDX)
Exelon Corporation (EXC)

View all positions for ExodusPoint Capital Management

Top funds holding Syros Pharmaceuticals

Bain Capital Life Sciences Investors
Siren
Samsara BioCapital
Point72 Asset Management
Flagship Ventures Management
Affinity Asset Advisors
Avidity Partners Management
Vanguard Group
Deep Track Capital
Opaleye Management
Blue Owl Capital Holdings
Kennedy Capital Management
ExodusPoint Capital Management
Goldman Sachs Group
BlackRock

View all funds holding Syros Pharmaceuticals